$48.56
-3.78-7.22%
Last update: Nov 11, 4:00 PM
Septerna Inc (SEPN) Stock Price, Quote, News & History
SEPNNASDAQ
Septerna gains Buy rating as HC Wainwright highlights undervaluation, strong pipeline, and key partnership with Novo Nordisk in metabolic diseases.
You can purchase shares of Septerna (NASDAQ:SEPN) through any online brokerage.
Other companies in Septerna’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Septerna has a consensus price target of $51.50.
The stock price for Septerna (NASDAQ: SEPN) is $48.56 last updated November 11, 2026 at 4:00 PM EST.
There are no upcoming dividends for Septerna.
Septerna does not have any upcoming earnings scheduled.
There is no upcoming split for Septerna.
Septerna is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the...
